Insider Transactions Reported by 10 Insiders of aTYR PHARMA INC

Symbol
ATYR on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

aTYR PHARMA INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PAUL SCHIMMEL Director $7,479,261 08 Oct 2025
Sanjay Shukla President and CEO, Director $629,655 03 Feb 2025
Jill Marie Broadfoot Chief Financial Officer $143,074 -$4,740 -3.2% 03 Feb 2025
NANCY DENYES General Counsel $116,866 -$3,398 -2.8% 03 Feb 2025
Timothy Coughlin Director $98,000 01 May 2025
Jane A. Gross Director $39,000 +$15,000 +62% 01 May 2025
Sara Zaknoen Director 01 May 2025
Svetlana Lucas Director 01 May 2025
ERIC BENEVICH Director 01 May 2025
JOHN K. CLARKE Director 22 May 2024

Recent Insider Transactions by Companies or Individuals for aTYR PHARMA INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.